141 related articles for article (PubMed ID: 32307917)
21. Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.
Yan B; Yau EX; Samanta S; Ong CW; Yong KJ; Ng LK; Bhattacharya B; Lim KH; Soong R; Yeoh KG; Deng N; Tan P; Lam Y; Salto-Tellez M;
Gastric Cancer; 2012 Apr; 15(2):188-97. PubMed ID: 21993851
[TBL] [Abstract][Full Text] [Related]
22. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
23. Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells.
Samse K; Emathinger J; Hariharan N; Quijada P; Ilves K; Völkers M; Ormachea L; De La Torre A; Orogo AM; Alvarez R; Din S; Mohsin S; Monsanto M; Fischer KM; Dembitsky WP; Gustafsson ÅB; Sussman MA
J Biol Chem; 2015 May; 290(22):13935-47. PubMed ID: 25882843
[TBL] [Abstract][Full Text] [Related]
24. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Holder SL; Abdulkadir SA
Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
[TBL] [Abstract][Full Text] [Related]
25. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
26. Nuclear PIM1 confers resistance to rapamycin-impaired endothelial proliferation.
Walpen T; Kalus I; Schwaller J; Peier MA; Battegay EJ; Humar R
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):24-30. PubMed ID: 23131564
[TBL] [Abstract][Full Text] [Related]
27. Pim1 kinase positively regulates myoblast behaviors and skeletal muscle regeneration.
Liu Y; Shang Y; Yan Z; Li H; Wang Z; Liu Z; Li Z
Cell Death Dis; 2019 Oct; 10(10):773. PubMed ID: 31601787
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor of breast cancer stem cells depending on the original breast cancers.
Xu WR; Lin HS; Chen XY; Zhang Y
Med Hypotheses; 2011 Jul; 77(1):71-3. PubMed ID: 21459518
[TBL] [Abstract][Full Text] [Related]
29. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
[TBL] [Abstract][Full Text] [Related]
30. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
[TBL] [Abstract][Full Text] [Related]
31. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
[TBL] [Abstract][Full Text] [Related]
33. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).
Jain MV; Jangamreddy JR; Grabarek J; Schweizer F; Klonisch T; Cieślar-Pobuda A; Łos MJ
Cell Cycle; 2015; 14(13):2109-20. PubMed ID: 26030190
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
Lai Y; Yu X; Lin X; He S
Int J Mol Med; 2016 Feb; 37(2):369-77. PubMed ID: 26707081
[TBL] [Abstract][Full Text] [Related]
35. PIM1 kinase as a target for cancer therapy.
Merkel AL; Meggers E; Ocker M
Expert Opin Investig Drugs; 2012 Apr; 21(4):425-36. PubMed ID: 22385334
[TBL] [Abstract][Full Text] [Related]
36. Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions.
Kumar A; Singhal M; Chopra C; Srinivasan S; Surabhi RP; Kanumuri R; Tentu S; Jagadeeshan S; Sundaram S; Ramanathan K; Shankar Pitani R; Muthuswamy B; Abhijit S; Nair AS; Venkatraman G; Rayala SK
Oncogene; 2016 Sep; 35(37):4857-65. PubMed ID: 26898755
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biological significance of PIM1 kinase in osteosarcoma.
Liao Y; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
J Orthop Res; 2016 Jul; 34(7):1185-94. PubMed ID: 26687194
[TBL] [Abstract][Full Text] [Related]
38. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.
Zemskova M; Sahakian E; Bashkirova S; Lilly M
J Biol Chem; 2008 Jul; 283(30):20635-44. PubMed ID: 18426800
[TBL] [Abstract][Full Text] [Related]
39. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
Iwatani K; Fujimoto T; Ito T
Biochem Biophys Res Commun; 2010 Sep; 400(3):426-31. PubMed ID: 20801098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
